Inventor · disambiguated record
Thomas W. Dubensky, Jr.
Also filed as: DUBENSKY JR THOMAS W · DUBENSKY JR THOMAS WALTER · DUBENSKY THOMAS · DUBENSKY THOMAS W
53 granted patents·40 pending applications·3,136 citations·filing 1994–2021
99Inventor score
Files withCHIRON CORP18ADURO BIOTECH INC17IMMUNE DESIGN CORP7NOVARTIS VACCINES & DIAGNOSTIC7ADURO BIOTECH6
Top patents by PatentIndex Score
93 records- 0199US5814482AEukaryotic layered vector initiation systemsFiled 1996·Granted Sep 29, 1998·536 cites·25 claims
- 0298US6015686AEukaryotic layered vector initiation systemsVIAGENE INC·Filed 1995·Granted Jan 18, 2000·253 cites·20 claims
- 0398US5843723AAlphavirus vector constructsCHIRON CORP·Filed 1996·Granted Dec 1, 1998·327 cites·47 claims
- 0498US5789245AAlphavirus structural protein expression cassettesCHIRON CORP·Filed 1996·Granted Aug 4, 1998·345 cites·29 claims
- 0597US9770467B2Compositions and methods for cancer immunotherapyUNIV JOHNS HOPKINS·Filed 2013·Granted Sep 26, 2017·31 cites·9 claims
- 0697US9198960B2Methods and compositions using listeria for enhancing immunogenicity by prime boostADURO BIOTECH INC·Filed 2015·Granted Dec 1, 2015·23 cites·4 claims
- 0797US7977091B2Eukaryotic layered vector initiation systemsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2009·Granted Jul 12, 2011·38 cites·4 claims
- 0897US7935804B2Engineered Listeria and methods of use thereofADURO BIOTECH·Filed 2006·Granted May 3, 2011·32 cites·84 claims
- 0996US6767699B2Method for the quantitation of alphavirus replicon particlesCHIRON CORP·Filed 2001·Granted Jul 27, 2004·50 cites·5 claims
- 1096US6376236B1Recombinant alphavirus particlesCHIRON CORP·Filed 1999·Granted Apr 23, 2002·121 cites·11 claims
- 1196US6329201B1Compositions and methods for packaging of alphavirus vectorsCHIRON CORP·Filed 2000·Granted Dec 11, 2001·86 cites·10 claims
- 1296US6015694AMethod for stimulating an immune response utilizing recombinant alphavirus particlesCHIRON CORP·Filed 1997·Granted Jan 18, 2000·228 cites·11 claims
- 1395US9724408B2Compositions and methods for activating stimulator of interferon gene-dependent signallingADURO BIOTECH INC·Filed 2014·Granted Aug 8, 2017·54 cites·6 claims
- 1495US9695212B2Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and useADURO BIOTECH INC·Filed 2013·Granted Jul 4, 2017·48 cites·11 claims
- 1595US9549944B2Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signallingADURO BIOTECH INC·Filed 2014·Granted Jan 24, 2017·53 cites·4 claims
- 1695US8287883B2Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereofDUBENSKY JR THOMAS W·Filed 2010·Granted Oct 16, 2012·17 cites·10 claims
- 1794US10189873B2Compositions and methods for inhibiting “stimulator of interferon gene”-dependent signallingADURO BIOTECH INC·Filed 2017·Granted Jan 29, 2019·10 cites·16 claims
- 1894US8926993B2Methods and compositions using Listeria for enhancing immunogenicity by prime boostDUBENSKY JR THOMAS W·Filed 2007·Granted Jan 6, 2015·26 cites·4 claims
- 1994US7811812B2Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesisNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Oct 12, 2010·43 cites·16 claims
- 2094US7771979B2Compositions and methods for generating an immune response utilizing alphavirus-based vector systemsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Granted Aug 10, 2010·39 cites·21 claims
- 2193US9044420B2Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responsesDUBENSKY JR THOMAS W·Filed 2012·Granted Jun 2, 2015·43 cites·33 claims
- 2293US6342372B1Eukaryotic layered vector initiation systems for production of recombinant proteinsCHIRON CORP·Filed 1999·Granted Jan 29, 2002·90 cites·14 claims
- 2392US8647864B2Compositions and methods for generating an immune response utilizing alphavirus-based vector systemsPOLO JOHN M·Filed 2010·Granted Feb 11, 2014·18 cites·21 claims
- 2492US7744900B2Enhancement of the immune response for vaccine and gene therapy applicationsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2008·Granted Jun 29, 2010·20 cites·15 claims
- 2591US6730297B1Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disordersCHIRON CORP·Filed 2000·Granted May 4, 2004·41 cites·13 claims
- 2690US9161974B2Methods and compositions using listeria for adjuvant treatment of cancerDUBENSKY THOMAS W·Filed 2011·Granted Oct 20, 2015·21 cites·8 claims
- 2790US6391632B1Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesisCHIRON CORP·Filed 1999·Granted May 21, 2002·63 cites·28 claims
- 2889US10449211B2Compositions and methods for activating “stimulator of interferon gene”—dependent signallingADURO BIOTECH INC·Filed 2016·Granted Oct 22, 2019·7 cites·10 claims
- 2989US10414789B2Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and useADURO BIOTECH INC·Filed 2017·Granted Sep 17, 2019·8 cites·12 claims
- 3089US8187872B2Lentiviral vectors pseudotyped with a sindbis virus envelope glycoproteinALLEN JAMES M·Filed 2011·Granted May 29, 2012·22 cites·30 claims
- 3189US6426196B1Alphavirus structural protein expression cassettesCHIRON CORP·Filed 1999·Granted Jul 30, 2002·57 cites·27 claims
- 3289US6242259B1Compositions and methods for packing of alphavirus vectorsCHIRON CORP·Filed 1999·Granted Jun 5, 2001·85 cites·72 claims
- 3388US9878024B2Methods and compositions using Listeria for enhancing immunogenicity by prime boostADURO BIOTECH INC·Filed 2015·Granted Jan 30, 2018·3 cites·10 claims
- 3488US7927606B2Modified free-living microbes, vaccine compositions and methods of use thereofADURO BIOTECH·Filed 2006·Granted Apr 19, 2011·5 cites·19 claims
- 3588US7572628B2Eukaryotic layered vector initiation systemsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Aug 11, 2009·9 cites·34 claims
- 3687US7842289B2Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereofADURO BIOTECH·Filed 2004·Granted Nov 30, 2010·23 cites·36 claims
- 3787US7833775B2Modified free-living microbes, vaccine compositions and methods of use thereofADURO BIOTECH·Filed 2004·Granted Nov 16, 2010·21 cites·17 claims
- 3886US10653774B2Compositions and methods for activating “stimulator of interferon gene”-dependent signallingADURO BIOTECH INC·Filed 2017·Granted May 19, 2020·5 cites·9 claims
- 3986US6451592B1Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesisCHIRON CORP·Filed 1997·Granted Sep 17, 2002·50 cites·26 claims
- 4085US8580939B2Engineered Listeria and methods of use thereofDUBENSKY JR THOMAS W·Filed 2011·Granted Nov 12, 2013·3 cites·18 claims
- 4184US10906930B2Compositions and methods for activating “stimulator of interferon gene”-dependent signallingADURO BIOTECH INC·Filed 2016·Granted Feb 2, 2021·3 cites·12 claims
- 4284US7695725B2Modified free-living microbes, vaccine compositions and methods of use thereofADURO BIOTECH·Filed 2004·Granted Apr 13, 2010·14 cites·16 claims
- 4384US7691393B2Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereofANZA THERAPEUTICS INC·Filed 2004·Granted Apr 6, 2010·22 cites·11 claims
- 4479US6465634B1Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesisCHIRON CORP·Filed 1999·Granted Oct 15, 2002·45 cites·25 claims
- 4578US5736388ABacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cellsFiled 1994·Granted Apr 7, 1998·53 cites·4 claims
- 4676US9555099B2Vaccines for HSV-2IMMUNE DESIGN CORP·Filed 2013·Granted Jan 31, 2017·2 cites·14 claims
- 4775US10391164B2Vaccines for HSV-2IMMUNE DESIGN CORP·Filed 2016·Granted Aug 27, 2019·1 cites·9 claims
- 4874US9663557B2Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereofADURO BIOTECH INC·Filed 2013·Granted May 30, 2017·2 cites·21 claims
- 4973US6458560B1Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesisCHIRON CORP·Filed 1999·Granted Oct 1, 2002·37 cites·24 claims
- 5071US9895435B2Vaccines for HSV-2IMMUNE DESIGN CORP·Filed 2013·Granted Feb 20, 2018·1 cites·14 claims
Showing the top 50 of 93 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Thomas W. Dubensky, Jr. files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →